Onco-Innovations is exploring a Nasdaq listing and possible stock sale to access U.S. investors.

Onco-Innovations has hired an investment bank to explore a Nasdaq cross-listing and possible simultaneous equity offering, signaling potential expansion into the U.S. capital markets. The move aims to increase visibility and access to broader investor bases, though no specific timeline or financial details have been disclosed.